allay

Lightstone Ventures, Temasek’s ClavystBio co-lead Allay Therapeutics’ US$57.5 million Series D funding
The company’s technology is used to create analgesic products that can aid patients with post-surgical pain management and recuperation[SINGAPORE] United States-based biotechnology company Allay Therapeutics on Thursday (Jun 5)...
